New study aims to ease cancer pain safely in seniors with kidney disease

NCT ID NCT07421674

First seen Feb 20, 2026 · Last updated May 16, 2026 · Updated 15 times

Summary

This study looks at whether a painkiller called hydromorphone can safely and effectively treat moderate to severe cancer pain in elderly patients (65+) who also have kidney problems. About 62 participants will receive the drug and be monitored for pain relief, kidney function, and side effects over 4 weeks. The goal is to find a better way to manage pain without harming the kidneys.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL INSUFFICIENCY CHRONIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tai'an Caner Hospital

    Tai’an, Shandong, 271000, China

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.